WHO ICTRP trial

Evaluation of the efficacy of curcumin in the management of advanced cancer…

CTRI/2008/091/000131 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2008/091/000131
Public title Evaluation of the efficacy of curcumin in the management of advanced cancer cervix.
Scientific title A prospective , randomized , double-blind , placebo-controlled, multicentric, phase III study of the efficacy of curcumin in the management of advanced cancer cervix.
Primary sponsor Department of Biotechnology
Secondary sponsors Department of Biotechnology, Block-2, CGO Complex , Lodhi Road, New Delhi 110003
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 3
Countries India
Conditions Health Condition 1: null- Advanced Ca Cevix
Interventions Intervention1: Curcumin: 4gms Control Intervention1: Placebo: 4gms
Registration date Jan 9, 2008
Target size 750
Secondary IDs DBT_090407
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations